Home
Single Company Reports
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
- Advertisment -
Tags
Destiny Pharma
Tag:
Destiny Pharma
Shares
AIM movers: Angle DNA breakthrough and ex-dividends
Andrew Hore
-
04/01/2024
5
Shares
AIM movers: Shoe Zone beats expectations again and i-nexus Global loses client
Andrew Hore
-
17/10/2023
1
Shares
AIM movers: Mercantile Ports contract and ex-dividends
Andrew Hore
-
25/05/2023
0
Shares
AIM weekly movers: Destiny Pharma secures partner but discounted placing hits share price
Andrew Hore
-
24/02/2023
10
Shares
AIM movers: Tekmar contract and ex-dividends
Andrew Hore
-
22/12/2022
3
Premium
Tip update: Disappointing Destiny still has potential
Andrew Hore
-
20/03/2022
2
Premium
Tip update: Long-term prospects still huge for Destiny Pharma
Andrew Hore
-
12/09/2021
0
Premium
TIP: The AIM share preventing hospital infections
Andrew Hore
-
06/06/2021
0
Premium
Destiny Pharma set for next phase
Andrew Hore
-
05/04/2021
0
Premium
Look out for XF-73 Destiny
Andrew Hore
-
28/03/2021
0
1
2
Page 1 of 2
Most Read
Six Stocks & Shares ISA ideas from the experts
28/03/2024
FTSE 100 rallies into Easter break, JD Sports jumps
28/03/2024
Major Tekcapital shareholder increases stake
28/03/2024
AIM movers: Molecular Energies leaving AIM and cancels Green House Capital float plus ex-dividends
28/03/2024